Moller_2018
Supportive Therapie · Version 2.1
|
Referenz (Autor, Jahr, Journal) |
Studientyp Mono- vs. Multizentrisch, Verblindung, Randomisierung, Arme, Fallzahl n, Land, Zeitraum
|
Patienten-merkmale Indikation, Alter, Geschlecht (m/w) |
Intervention Fallzahl n, Beschreibung der präventiven bzw. therapeutischen Maßnahme |
Kontrolle Fallzahl n, Beschreibung der präventiven Maßnahme bzw. therapeutischen Maßnahme |
Zielgrößen Primärer Endpunkt Sekundäre(r) Endpunkt(e) |
Primärer Endpunkt Angaben für Intervention vs. Kontrolle |
Sekundäre(r) Endpunkt(e) Angaben für Intervention vs. Kontrolle |
Finanzierung |
Evidenzstufe Bei Abwertung: Angabe von Gründen Bewertung des Autors |
|
Møller
2018
Technical Innovations & Patient Support in Radiation Oncology |
intra-patient randomized multicentre study
3 centre
N = 101
Denmark
10/2015 – 02/2016
|
breast cancer patients
postoperative adjuvant radiotherapy
hypo-fractionated breast radiotherapy based on 40 Gy/15 fractions in 3 weeks
Age, mean: 61.9 (range 31–82)
BMI, mean: 26.5 |
lateral part of the chest was covered by Mepitel film |
medial part of the chest was covered by Mepitel film |
primary endpoint: patient reported symptoms and experience
secondary endpoint: radiotherapy staff evaluation of dermatitis |
Mepitel film vs. Standard care
skin area covered by film: lower level of pain (p < 0.001), itching (p = 0.005), burning sensation (p = 0.005), edema (p = 0.017) and reduced sensitivity (p < 0.001).
Most patients (76%) would have preferred film on the entire treatment area (p < 0.001) and Mepitel Film as a standard treatment option (84%) (p < 0.001). Patients treated after mastectomy had a significantly lower severity of radiation-induced dermatitis with film at the end of RT compared to standard care (p = 0.005). However, in the blinded staff evaluation, no significant differences were found at follow-up |
Observer-rated radiodermatitis
Last day of RT (n = 76) Mepitel film Standard care Grade 0: 24 (31%) vs. 21 (28%) Grade 1: 47 (62%) vs. 44 (58%) Grade 2: 5 (7%) vs. 10 (13%) Grade 3: 0 vs. 1 (1%) P=0.100 14 days after RT (n = 79) Mepitel film Standard care Grade 0: 20 (25%) vs. 20 (25%) Grade 1: 53 (67%) vs. 49 (62%) Grade 2: 6 (8%) vs. 10 (13%) Grade 3: 0 vs. 0 P=0.493 |
The authors declare no conflict of interest. |
2
dropouts were not included in the final analyses
"Patients reported reduced symptoms from the skin with Mepitel Film and the majority would have preferred film as a standard offer to cover their entire treatment area. Especially women treated after mastectomy had a significantly lower level of radiodermatitis and preferred the film over standard care." |